Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 66, Issue 10, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/aac.00695-22
Keywords
nonreplicating persister; pretomanid; moxifloxacin; bedaquiline; combination chemotherapy; Mycobacterium tuberculosis; combination therapy; nonparametric
Categories
Funding
- NIAID [P01 AI123036]
Ask authors/readers for more resources
The study utilized a model-informed strategy to test the efficacy of drug combinations against nonreplicating persister (NRP) phenotype of Mycobacterium tuberculosis. The results showed that the two-drug combination of pretomanid and moxifloxacin effectively eradicated Mtb, while the addition of bedaquiline as a third drug significantly shortened the time to total bacterial suppression.
Mycobacterium tuberculosis (Mtb) exists in various metabolic states, including a nonreplicating persister (NRP) phenotype which may affect response to therapy. We have adopted a model-informed strategy to accelerate discovery of effective Mtb treatment regimens and previously found pretomanid (PMD), moxifloxacin (MXF), and bedaquiline (BDQ) to readily kill logarithmic- and acid-phase Mtb. Here, we studied multiple concentrations of each drug in flask-based, time-kill studies against NRP Mtb in single-, two- and three-drug combinations, including the active M2 metabolite of BDQ. We used nonparametric population algorithms in the Pmetrics package for R to model the data and to simulate the 95% confidence interval of bacterial population decline due to the two-drug combination regimen of PMD + MXF and compared this to observed declines with three-drug regimens. PMD - MXF at concentrations equivalent to average or peak human concentrations effectively eradicated Mtb. Unlike other states for Mtb, we observed no sustained emergence of less susceptible isolates for any regimen. The addition of BDQ as a third drug significantly (P < 0.05) shortened time to total bacterial suppression by 3 days compared to the two-drug regimen, similar to our findings for Mtb in logarithmic or acid growth phases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available